Sophy®

Product Description

Sophy® is a food supplement specifically developed for women with Polycystic Ovary Syndrome (PCOS), supporting both reproductive and metabolic health.

Each tablet contains 550 mg of Berberine Phytosome®, an innovative formulation designed to significantly enhance berberine bioavailability and efficacy.

Clinical studies in women with PCOS have shown marked improvements in key manifestations of the condition, including an 80% reduction in menstrual disorders, a 70% reduction in ovarian polycystosis and a 55% reduction in acne. Berberine Phytosome® has also demonstrated beneficial effects on glucose metabolism and insulin resistance.

PHARMEXTRACTA S.P.A.

Country/Region:

Italy
On CPHI since:

2020
Employees:

100 - 249

Company types

Distributor/Import Export

Wholesale/Retail

Compare Add to favorites Added to favorites

Specifications

Details

Food supplement containing 550 mg of Berberine Phytosome® per tablet, specifically developed for women with Polycystic Ovary Syndrome (PCOS). Designed to support menstrual cycle regularity and improve key manifestations associated with PCOS, including ovarian polycystosis, acne and metabolic alterations.
Selling Points
Natural Ingredients; Product Features; Product Performance; Clinically studied Berberine Phytosome® formulation specifically developed for women with PCOS. Phytosome® technology enhances berberine bioavailability and efficacy. Clinical studies have shown marked improvements in menstrual disorders, ovarian polycystosis and acne, together with beneficial effects on glucose metabolism and insulin resistance. Winner of the 2024 NutraIngredients Award for Botanical Product of the Year.
Model

Tablets
Supplied from

Italy
Measured In
piece